These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34430458)

  • 1. Prospective Study of Growth Factor Concentrate Therapy for Treatment of Melasma.
    Sthalekar B; Agarwal M; Sharma V; Patil CY; Desai M
    Indian Dermatol Online J; 2021; 12(4):549-554. PubMed ID: 34430458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study.
    Abd Elraouf IG; Obaid ZM; Fouda I
    Arch Dermatol Res; 2023 Aug; 315(6):1763-1770. PubMed ID: 36856856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-rich plasma treatment for melasma: A pilot study.
    Sirithanabadeekul P; Dannarongchai A; Suwanchinda A
    J Cosmet Dermatol; 2020 Jun; 19(6):1321-1327. PubMed ID: 31568636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous intralesional platelet rich plasma improves melasma.
    Tuknayat A; Thami GP; Bhalla M; Sandhu JK
    Dermatol Ther; 2021 Mar; 34(2):e14881. PubMed ID: 33591615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal Tranexamic Acid Injection for the Treatment of Melasma: A Pilot Study with 48-week Follow-up.
    Lueangarun S; Sirithanabadeekul P; Wongwicharn P; Namboonlue C; Pacharapakornpong S; Juntongjin P; Tempark T
    J Clin Aesthet Dermatol; 2020 Aug; 13(8):36-39. PubMed ID: 33178380
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet-rich plasma is a useful therapeutic option in melasma.
    Hofny ERM; Abdel-Motaleb AA; Ghazally A; Ahmed AM; Hussein MRA
    J Dermatolog Treat; 2019 Jun; 30(4):396-401. PubMed ID: 30220226
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and Safety of Using Noninsulated Microneedle Radiofrequency Alone Versus in Combination with Polynucleotides for the Treatment of Melasma: A Pilot Study.
    Gulfan MCB; Wanitphakdeedecha R; Wongdama S; Jantanapornchai N; Yan C; Rakchart S
    Dermatol Ther (Heidelb); 2022 Jun; 12(6):1325-1336. PubMed ID: 35538360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, Placebo-controlled Trial to Evaluate the Effectiveness of
    Goh CL; Chuah SY; Tien S; Thng G; Vitale MA; Delgado-Rubin A
    J Clin Aesthet Dermatol; 2018 Mar; 11(3):14-19. PubMed ID: 29606995
    [No Abstract]   [Full Text] [Related]  

  • 9. Dual Toning Method with the Combination of Picosecond and Microsecond Nd:YAG in Refractory Melasma Unresponsive to Picosecond Alone.
    Hai L; Phuong B; Ha L; Lam V; Van B; Al-Niaimi F
    J Cutan Aesthet Surg; 2021; 14(1):101-106. PubMed ID: 34084016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, open-label study to compare two different dosing regimens of oral tranexamic acid in treatment of moderate to severe facial melasma.
    Bhattacharjee R; Hanumanthu V; Thakur V; Bishnoi A; Vinay K; Kumar A; Parsad D; Kumaran MS
    Arch Dermatol Res; 2023 Aug; 315(6):1831-1836. PubMed ID: 36757440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
    Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
    Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of superficial micro-focused ultrasound with visualization for melasma in Asians: An uncontrolled pilot study.
    Lim JTE
    J Cosmet Dermatol; 2023 Jun; 22(6):1764-1773. PubMed ID: 36762392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of autologous platelet-rich-plasma versus its combination with intense pulsed light in treatment of melasma.
    Adel S; Serri A; Abd El-Raheem T
    Dermatol Ther; 2021 Jul; 34(4):e15008. PubMed ID: 34041826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Platelet-Rich Plasma in Melasma: A Systematic Review and Meta-Analysis.
    Zhao L; Hu M; Xiao Q; Zhou R; Li Y; Xiong L; Li L
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1587-1597. PubMed ID: 34269967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
    Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
    Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. French maritime pine bark extract (pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a double-blind, randomized, placebo-controlled trial.
    Lima PB; Dias JAF; Esposito ACC; Miot LDB; Miot HA
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):502-508. PubMed ID: 32841433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
    Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial.
    Lima PB; Dias JAF; Cassiano DP; Esposito ACC; Miot LDB; Bagatin E; Miot HA
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1881-1887. PubMed ID: 33988887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.